All Articles

Ontario to try again to put patient health records online

Published: 20260319T200000Z

Show HN: I built a P2P network where AI agents publish formally verified science

I am Francisco, a researcher from Spain. My English is not great so please be patient with me. One year ago I had a simple frustration: every AI agent works alone. When one agent solves a problem, the next agent has to solve it again from zero. There is no way for agents to find each other, share results, or build on each other's work. I decided to build the missing layer. P2PCLAW is a peer-to-peer network where AI agents and human researchers can find each other, publish scientific results, and validate claims using formal mathematical proof. Not opinion. Not LLM review. Real Lean 4 proof. A result is accepted only if it passes a mathematical operator we call the nucleus. R(x) = x. The type checker decides. It does not care about your institution or your credentials. The network uses GUN.js and IPFS. Agents join without accounts. They just call GET /silicon and they are in. Published papers go into a queue called mempool. After validation by independent nodes they enter La Rueda, which is our permanent IPFS archive. Nobody can delete it or change it. We also built a security layer called AgentHALO. It uses post-quantum cryptography (ML-KEM-768 and ML-DSA-65, FIPS 203 and 204), a privacy network called Nym so agents in restricted countries can participate safely, and proofs that let anyone verify what an agent did without seeing its private data. The formal verification part is called HeytingLean. It is Lean 4. 3325 source files. More than 760000 lines of mathematics. Zero sorry. Zero admit. The security proofs are machine checked, not just claimed. The system is live now. You can try it as an agent: GET https://p2pclaw.com/agent-briefing Or as a researcher: https://app.p2pclaw.com We have no money and no company behind us. Just a small international team of researchers and doctors who think that scientific knowledge should be public and verifiable. I want feedback from HN specifically about three technical decisions: why we chose GUN.js instead of libp2p, whether o

Admin touts TrumpRX success: it's a quick fix, not real progress!

A new analysis from The New York Times, along with German outlets NDR and WDR, took a closer look at the administration’s new drug pricing platform, TrumpRx. What they found is that while some prices have come down, Americans are still paying significantly more than patients in other wealthy countries,

Large specialty practice uses agentic AI to strengthen patient engagement

Published: 20260319T173000Z

New partnership to fast - track Canadian health technology from innovation to patient care

Published: 20260319T173000Z

STAT+: Pharmalittle: We’re reading about a Lilly weight loss trial, TrumpRx shortcomings, and more

Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in a late-stage study

STAT+: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial

Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in a late-stage study.

STAT+: HHS watchdog slams nursing homes’ antipsychotic drug use and schizophrenia diagnoses

Nursing homes misuse antipsychotic drugs for dementia patients, disguise practice as schizophrenia treatment, watchdog finds.

Mark Cuban says Trump Rx saving people 'a lot of money' on some drugs

Billionaire enterpreneur Mark Cuban on Wednesday touted the federal government’s TrumpRx drug platform, saying the initiative is saving Americans money. “Everyone wants me to rip on TrumpRx,” Cuban wrote on the social platform X. “Reality is, it’s saving patients money on IVF and a few other drugs. A lot of money. IMO, anything that saves...

STAT+: A Maryland legislator wants pharma and patient groups to disclose ties to disease awareness campaigns

A bill introduced in the Maryland legislature would require drugmakers to disclose ties to disease awareness campaigns.

Comme au début du sida , on ne comprend pas tout : six ans après , le covid long défie la médecine et laisse des milliers de patients sans réponse

Published: 20260318T163000Z

Malaysian medical tourism set to benefit from Iran war’s impact

Malaysia’s medical tourism sector could receive a boost amid the widening conflict in the Middle East as potential patients look for safer alternatives in Asia, according to a private healthcare company. Dubai, the main medical hub in the region, has been under Iranian missile and drone retaliatory attacks since the US and Israel began air strikes on the Islamic Republic on February 28. This could prompt Middle Easterners who are seeking medical treatment to travel to Southeast Asian countries...

STAT+: How a Texas couple is getting rich off out-of-network medical bills

STAT investigates how a Texas couple cashed in on a new law that's supposed to protect patients from surprise medical bills.

New drug protects liver after intestinal surgery and boosts nutrient absorption

A risky but often lifesaving surgery that removes damaged parts of the small intestine can leave patients facing a new threat: serious liver damage with no available treatment. Now, scientists have developed a promising compound that works directly in the gut to shield the liver and improve how the body absorbs nutrients. In mouse studies, the drug boosted weight gain, reduced harmful liver scarring, and avoided side effects by staying confined to the intestines.

Two patients die during fire evacuation at Barishal hospital

Published: 20260318T060000Z

Thymic health and immunotherapy outcomes in patients with cancer

Air strike hit Kabul rehab centre as patients ate dinner, survivor tells BBC

The exact number killed in Monday night's strike by Pakistan is still not known, but is feared to be in the hundreds.

Scientists inject one tumor and watch cancer vanish across the body

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission.

Common pesticide may more than double Parkinson’s disease risk

A new UCLA Health study suggests that long-term exposure to the pesticide chlorpyrifos may dramatically raise the risk of Parkinson’s disease. Researchers found that people living in areas with sustained exposure had more than 2.5 times the likelihood of developing the disorder. Lab experiments reinforced the finding: animals exposed to the chemical developed movement problems, lost dopamine-producing neurons, and showed the same toxic protein buildup seen in Parkinson’s patients.

Ten ICU patients killed in hospital fire in eastern India

Emergency responders carried patients out of a government hospital in Odisha, India.

STAT+: Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says

After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial financial and treatment problems, according to a new report.

Close all wards at Queen Elizabeth University Hospital that put patients at risk

Published: 20260316T180000Z

STAT+: Pharmalittle: We’re reading about obesity pill trial results, cholesterol guidelines, and more

Structure Therapeutics disclosed that its daily obesity pill led patients to lose about 16% of their body weight relative to placebo after 44 weeks

STAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill

An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a Phase 3 study in the works.